Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Duckworth

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
Control of cardiovascular risk factors in the Veterans Affairs Diabetes Trial in advanced type 2 diabetesWilliam C Duckworth, Madeline McCarren, Carlos Abraira, et al.
Postgraduate Medicine|December 7, 2017
Pancreas transplantation for type I diabetes mellitusJennifer L Larsen, William C Duckworth, Robert J Stratta
Diabetes|August 28, 2003
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell culturesRobert G Bennett, Frederick G Hamel, William C Duckworth
The American Journal of the Medical Sciences|February 18, 2003
Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitusSyed U Bokhari, Usha M Gopal, William C Duckworth
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Insulin-degrading activity in wound fluidWilliam C Duckworth, Janet Fawcett, Sreedevi Reddy, et al.
Biochemical and Biophysical Research Communications|April 6, 2010
Retinoblastoma protein co-purifies with proteasomal insulin-degrading enzyme: implications for cell proliferation controlRazvan T Radulescu, William C Duckworth, Jennifer L Levy, et al.
Archives of Biochemistry and Biophysics|October 30, 2007
Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencingJanet Fawcett, Paska A Permana, Jennifer L Levy, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|April 13, 2004
Control of proteolysis: hormones, nutrients, and the changing role of the proteasomeFrederick G Hamel, Janet Fawcett, Robert G Bennett, et al.
Metabolism: Clinical and Experimental|July 29, 2004
Reduced action of insulin glargine on protein and lipid metabolism: possible relationship to cellular hormone metabolismJanet Fawcett, Brian T Tsui, Michael C Kruer, et al.
Metabolism: Clinical and Experimental|July 19, 2003
Inhibition of proteasome activity by selected amino acidsFrederick G Hamel, Jennifer L Upward, Gerri L Siford, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
Control of cardiovascular risk factors in the Veterans Affairs Diabetes Trial in advanced type 2 diabetesWilliam C Duckworth, Madeline McCarren, Carlos Abraira, et al.
Postgraduate Medicine|December 7, 2017
Pancreas transplantation for type I diabetes mellitusJennifer L Larsen, William C Duckworth, Robert J Stratta
Diabetes|August 28, 2003
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell culturesRobert G Bennett, Frederick G Hamel, William C Duckworth
The American Journal of the Medical Sciences|February 18, 2003
Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitusSyed U Bokhari, Usha M Gopal, William C Duckworth
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Insulin-degrading activity in wound fluidWilliam C Duckworth, Janet Fawcett, Sreedevi Reddy, et al.
Biochemical and Biophysical Research Communications|April 6, 2010
Retinoblastoma protein co-purifies with proteasomal insulin-degrading enzyme: implications for cell proliferation controlRazvan T Radulescu, William C Duckworth, Jennifer L Levy, et al.
Archives of Biochemistry and Biophysics|October 30, 2007
Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencingJanet Fawcett, Paska A Permana, Jennifer L Levy, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|April 13, 2004
Control of proteolysis: hormones, nutrients, and the changing role of the proteasomeFrederick G Hamel, Janet Fawcett, Robert G Bennett, et al.
Metabolism: Clinical and Experimental|July 29, 2004
Reduced action of insulin glargine on protein and lipid metabolism: possible relationship to cellular hormone metabolismJanet Fawcett, Brian T Tsui, Michael C Kruer, et al.
Metabolism: Clinical and Experimental|July 19, 2003
Inhibition of proteasome activity by selected amino acidsFrederick G Hamel, Jennifer L Upward, Gerri L Siford, et al.
Pageof 4